These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 35745588)

  • 1. QSAR, ADMET In Silico Pharmacokinetics, Molecular Docking and Molecular Dynamics Studies of Novel Bicyclo (Aryl Methyl) Benzamides as Potent GlyT1 Inhibitors for the Treatment of Schizophrenia.
    El Fadili M; Er-Rajy M; Kara M; Assouguem A; Belhassan A; Alotaibi A; Mrabti NN; Fidan H; Ullah R; Ercisli S; Zarougui S; Elhallaoui M
    Pharmaceuticals (Basel); 2022 May; 15(6):. PubMed ID: 35745588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. QSAR, ADME-Tox, molecular docking and molecular dynamics simulations of novel selective glycine transporter type 1 inhibitors with memory enhancing properties.
    El Fadili M; Er-Rajy M; Imtara H; Noman OM; Mothana RA; Abdullah S; Zerougui S; Elhallaoui M
    Heliyon; 2023 Feb; 9(2):e13706. PubMed ID: 36865465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Study of novel triazolo-benzodiazepine analogues as antidepressants targeting by molecular docking and ADMET properties prediction.
    Belhassan A; Zaki H; Benlyas M; Lakhlifi T; Bouachrine M
    Heliyon; 2019 Sep; 5(9):e02446. PubMed ID: 31528753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In silico evidence of bitopertin's broad interactions within the SLC6 transporter family.
    de Carvalho GA; Tambwe PM; Nascimento LRC; Campos BKP; Chiareli RA; Junior GPN; Menegatti R; Gomez RS; Pinto MCX
    J Pharm Pharmacol; 2024 Sep; 76(9):1199-1211. PubMed ID: 38982944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of novel monoamine oxidase B (MAO-B) inhibitors by combined application of docking-based alignment, 3D-QSAR, ADMET prediction, molecular dynamics simulation, and MM_GBSA binding free energy.
    El Aissouq A; Chedadi O; Bouachrine M; Ouammou A; Khalil F
    J Biomol Struct Dyn; 2023 Jul; 41(10):4667-4680. PubMed ID: 35510607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacophore generation, atom-based 3D-QSAR, molecular docking and molecular dynamics simulation studies on benzamide analogues as FtsZ inhibitors.
    Tripathy S; Azam MA; Jupudi S; Sahu SK
    J Biomol Struct Dyn; 2018 Sep; 36(12):3218-3230. PubMed ID: 28938860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-Based Design and in Silico Screening of Virtual Combinatorial Library of Benzamides Inhibiting 2-trans Enoyl-Acyl Carrier Protein Reductase of
    Kouman KC; Keita M; Kre N'Guessan R; Owono Owono LC; Megnassan E; Frecer V; Miertus S
    Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31554227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of potent aldose reductase inhibitors as antidiabetic (Anti-hyperglycemic) agents using QSAR based virtual Screening, molecular Docking, MD simulation and MMGBSA approaches.
    Bakal RL; Jawarkar RD; Manwar JV; Jaiswal MS; Ghosh A; Gandhi A; Zaki MEA; Al-Hussain S; Samad A; Masand VH; Mukerjee N; Nasir Abbas Bukhari S; Sharma P; Lewaa I
    Saudi Pharm J; 2022 Jun; 30(6):693-710. PubMed ID: 35812153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitors of GlyT1 affect glycine transport via discrete binding sites.
    Mezler M; Hornberger W; Mueller R; Schmidt M; Amberg W; Braje W; Ochse M; Schoemaker H; Behl B
    Mol Pharmacol; 2008 Dec; 74(6):1705-15. PubMed ID: 18815213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. QSAR modelling, molecular docking, molecular dynamic and ADMET prediction of pyrrolopyrimidine derivatives as novel Bruton's tyrosine kinase (BTK) inhibitors.
    Aloui M; Er-Rajy M; Imtara H; Goudzal A; Zarougui S; El Fadili M; Arthur DE; Mothana RA; Noman OM; Tarayrah M; Menana E
    Saudi Pharm J; 2024 Jan; 32(1):101911. PubMed ID: 38226346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. QSAR based docking studies of marine algal anticancer compounds as inhibitors of protein kinase B (PKBβ).
    Davis GD; Vasanthi AH
    Eur J Pharm Sci; 2015 Aug; 76():110-8. PubMed ID: 25936945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Computational investigation of imidazo[2,1-b]oxazole derivatives as potential mutant BRAF kinase inhibitors: 3D-QSAR, molecular docking, molecular dynamics simulation, and ADMETox studies.
    Boutalaka M; El Bahi S; Alaqarbeh M; El Alaouy MA; Koubi Y; Khatabi KE; Maghat H; Bouachrine M; Lakhlifi T
    J Biomol Struct Dyn; 2024 Jul; 42(10):5268-5287. PubMed ID: 37424193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In silico design of novel CDK2 inhibitors through QSAR, ADMET, molecular docking and molecular dynamics simulation studies.
    Moussaoui M; Baassi M; Baammi S; Soufi H; Salah M; Daoud R; El Allali A; Belghiti ME; Belaaouad S
    J Biomol Struct Dyn; 2023; 41(23):13646-13662. PubMed ID: 37203327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design of novel DABO derivatives as HIV-1 RT inhibitors using molecular docking, molecular dynamics simulations and ADMET properties.
    Zhang Y; Chen L; Wang Z; Zhu Y; Jiang H; Xu J; Xiong F
    J Biomol Struct Dyn; 2024 May; 42(8):4196-4213. PubMed ID: 37272892
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Akabli T; Toufik H; Lamchouri F
    J Biomol Struct Dyn; 2022 Jun; 40(9):3965-3978. PubMed ID: 33252029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An In Silico Study Based on QSAR and Molecular Docking and Molecular Dynamics Simulation for the Discovery of Novel Potent Inhibitor against AChE.
    Khedraoui M; Abchir O; Nour H; Yamari I; Errougui A; Samadi A; Chtita S
    Pharmaceuticals (Basel); 2024 Jun; 17(7):. PubMed ID: 39065681
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Shirvani P; Fassihi A
    J Biomol Struct Dyn; 2022 Aug; 40(13):5965-5982. PubMed ID: 33475043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design of novel benzimidazole derivatives as potential α-amylase inhibitors using QSAR, pharmacokinetics, molecular docking, and molecular dynamics simulation studies.
    Abchir O; Daoui O; Belaidi S; Ouassaf M; Qais FA; ElKhattabi S; Belaaouad S; Chtita S
    J Mol Model; 2022 Mar; 28(4):106. PubMed ID: 35352175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of cathinone analogs targeting human dopamine transporter using molecular modeling.
    Shivankar BR; Bhandare VV; Joshi K; Patil VS; Dhotare PS; Sonawane KD; Krishnamurty S
    J Biomol Struct Dyn; 2024 May; ():1-16. PubMed ID: 38698732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. QSAR, homology modeling, and docking simulation on SARS-CoV-2 and pseudomonas aeruginosa inhibitors, ADMET, and molecular dynamic simulations to find a possible oral lead candidate.
    Edache EI; Uzairu A; Mamza PA; Shallangwa GA
    J Genet Eng Biotechnol; 2022 Dec; 20():88. PubMed ID: 35730025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.